NCT00534651View on ClinicalTrials.gov

Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Coronary ArteriosclerosisEndothelial Function
Interventions
DRUG

Paracetamol

Paracetamol 3x1000mg daily or Placebo for two weeks in a crossover design with a two-week washout-phase in between.

Trial Locations (1)

8091

University Hospital, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT00534651 - Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease | Biotech Hunter | Biotech Hunter